Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
BCG Dose and Maintenance in NMIBC
NCT00002990Phase 3Completed
- Sponsor
- European Organisation for Research and Treatment of Cancer
- Start
- Mar 1997
- Primary completion
- Apr 2005
- Modality
- Vaccines & Immunotherapeutics
- Countries
- 11
01
Overview
A Phase 3 trial of bcg vaccine in bladder cancer, sponsored by European Organisation for Research and Treatment of Cancer. Started Mar 1997; status: completed.
02
Drugs
bcg vaccine
03
Conditions
bladder cancer
Beyond the preview
Go deeper on NCT00002990.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00002990.